| Literature DB >> 30577044 |
Thouraya Ben Younes1, Hanene Benrhouma1,2, Hedia Klaa1,2, Rania Ben Aoun1,2, Aida Rouissi1,2, Melika Ben Ahmed2,3, Ichraf Kraoua1,2, Ilhem Ben Youssef-Turki1,2.
Abstract
Myasthenia gravis (MG) with antibodies to the muscle-specific tyrosine kinase (MuSK-MG) receptor is a rare entity. It represents 5 to 8% of all MG patients. Few pediatric cases were reported. Clinical presentation is often atypical. It is characterized by predominant involvement of cranial, bulbar, and axial muscles and early respiratory crises. Myokymia and fasciculation are suggestive of MuSK-MG. The clinical course of patients with MuSK-MG is worse than other types of MG. Responses to standard therapies are variable. We report clinical, neurophysiological, serological, and outcome profile of a Tunisian child with MuSK-MG. Georg Thieme Verlag KG Stuttgart · New York.Entities:
Year: 2018 PMID: 30577044 DOI: 10.1055/s-0038-1676514
Source DB: PubMed Journal: Neuropediatrics ISSN: 0174-304X Impact factor: 1.947